These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 15720966)

  • 1. Post-transfusion purpura.
    Gonzalez CE; Pengetze YM
    Curr Hematol Rep; 2005 Mar; 4(2):154-9. PubMed ID: 15720966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-transfusion purpura: a challenging diagnosis.
    Shtalrid M; Shvidel L; Vorst E; Weinmann EE; Berrebi A; Sigler E
    Isr Med Assoc J; 2006 Oct; 8(10):672-4. PubMed ID: 17125110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alloimmunization to platelet antigens.
    Nugent DJ
    Semin Hematol; 1992 Jul; 29(3 Suppl 2):83-8. PubMed ID: 1509298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The management of alloimmune neonatal thrombocytopenia.
    Blanchette VS; Johnson J; Rand M
    Baillieres Best Pract Res Clin Haematol; 2000 Sep; 13(3):365-90. PubMed ID: 11030040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical and serologic studies in 34 patients with post-transfusion purpura].
    Kroll H; Kiefel V; Mueller-Eckhardt C
    Beitr Infusionsther; 1992; 30():403-7. PubMed ID: 1284746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A second case of post-transfusion purpura caused by HPA-5a antibodies: successful treatment with intravenous immunoglobulin.
    Ziman A; Klapper E; Pepkowitz S; Smith R; Garratty G; Goldfinger D
    Vox Sang; 2002 Aug; 83(2):165-6. PubMed ID: 12201847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Post transfusion purpura--a serious underdiagnosed delayed post-transfusion event].
    Maślanka K; Zupańska B
    Pol Merkur Lekarski; 2006 Jun; 20(120):660-3. PubMed ID: 17007262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-HPA-9bw (Maxa) fetomaternal alloimmunization, a clinically severe neonatal thrombocytopenia: difficulties in diagnosis and therapy and report on eight families.
    Kaplan C; Porcelijn L; Vanlieferinghen P; Julien E; Bianchi F; Martageix C; Bertrand G; Jallu V
    Transfusion; 2005 Nov; 45(11):1799-803. PubMed ID: 16271107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pan-reactive platelet antibodies in post-transfusion purpura.
    Taaning E; Tønnesen F
    Vox Sang; 1999; 76(2):120-3. PubMed ID: 10085529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-transfusion purpura: case report.
    Kumar R; Ghali A; Ekaldious AW; Mahmoud OI; Al-Lumai AS
    Ann Hematol; 2001 Aug; 80(8):488-91. PubMed ID: 11563598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relevance of the HPA-15 (Gov) polymorphism on CD109 in alloimmune thrombocytopenic syndromes.
    Ertel K; Al-Tawil M; Santoso S; Kroll H
    Transfusion; 2005 Mar; 45(3):366-73. PubMed ID: 15752154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The management of feto-maternal alloimmune thrombocytopenia: report of three cases.
    Paternoster DM; Cester M; Memmo A; Scandellari R; Fabris F; Girolami A
    J Matern Fetal Neonatal Med; 2006 Aug; 19(8):517-20. PubMed ID: 16966118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of HPA-1a (PlA1)-negative platelets in a patient with post-transfusion purpura.
    Loren AW; Abrams CS
    Am J Hematol; 2004 Jul; 76(3):258-62. PubMed ID: 15224362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidental diagnosis and tempestive therapy in a case of neonatal alloimmune thrombocytopenia due to anti-HPA-5b.
    Zuppa AA; Cota F; De Luca D; Visintini F; De Turris PL; Tortorolo G
    Pediatr Hematol Oncol; 2002 Dec; 19(8):587-91. PubMed ID: 12487835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-HPA-1a in a case of post-transfusion purpura: binding to antigen-negative platelets detected by adsorption/elution.
    Kiefel V; Schönberner-Richter I; Schilf K
    Transfus Med; 2005 Jun; 15(3):243-7. PubMed ID: 15943711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alloimmunization against human platelet antigen 2 (HPA2) in a series of multi-transfused beta-thalassemia patients.
    Tazzari PL; Ricci F; Tassi C; Bontadini A; Fruet F; Conte R
    Haematologica; 1998 Aug; 83(8):765-6. PubMed ID: 9793272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Posttransfusion purpura associated with alloantibody specific for the platelet antigen, Pen(a).
    Simon TL; Collins J; Kunicki TJ; Furihata K; Smith KJ; Aster RH
    Am J Hematol; 1988 Sep; 29(1):38-40. PubMed ID: 2459963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of transfusion-induced platelet-reactive antibodies evaluated by specific assays for the detection of human leucocyte antigen and human platelet antigen antibodies.
    Fontão-Wendel R; Silva LC; Saviolo CB; Primavera B; Wendel S
    Vox Sang; 2007 Oct; 93(3):241-9. PubMed ID: 17845262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-transfusion purpura in a patient with HPA-1a and GPIa/IIa antibodies.
    Woelke C; Eichler P; Washington G; Flesch BK
    Transfus Med; 2006 Feb; 16(1):69-72. PubMed ID: 16480442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post-transfusion purpura (PTP) associated with anti-HPA-1a, anti-HPA-2b and anti-HPA-3a antibodies.
    Lucas GF; Pittman SJ; Davies S; Solanki T; Brüggemann K
    Transfus Med; 1997 Dec; 7(4):295-9. PubMed ID: 9510928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.